Zhu Wen, Carney Karen E, Pigott Victoria M, Falgoust Lindsay M, Clark Paul A, Kuo John S, Sun Dandan
Department of Neurology, University of Pittsburgh , Pittsburgh, PA 15213 , USA.
Department of Neurological Surgery.
Carcinogenesis. 2016 Sep;37(9):839-851. doi: 10.1093/carcin/bgw068. Epub 2016 Jun 9.
Microglia play important roles in extracellular matrix remodeling, tumor invasion, angiogenesis, and suppression of adaptive immunity in glioma. Na(+)/H(+) exchanger isoform 1 (NHE1) regulates microglial activation and migration. However, little is known about the roles of NHE1 in intratumoral microglial activation and microglia-glioma interactions. Our study revealed up-regulation of NHE1 protein expression in both glioma cells and tumor-associated Iba1(+) microglia in glioma xenografts and glioblastoma multiforme microarrays. Moreover, we observed positive correlation of NHE1 expression with Iba1 intensity in microglia/macrophages. Glioma cells, via conditioned medium or non-contact glioma-microglia co-cultures, concurrently upregulated microglial expression of NHE1 protein and other microglial activation markers (iNOS, arginase-1, TGF-β, IL-6, IL-10 and the matrix metalloproteinases MT1-MMP and MMP9). Interestingly, glioma-stimulated microglia reciprocally enhanced glioma proliferation and migration. Most importantly, inhibition of microglial NHE1 activity via small interfering RNA (siRNA) knockdown or the potent NHE1-specific inhibitor HOE642 significantly attenuated microglial activation and abolished microglia-stimulated glioma migration and proliferation. Taken together, our findings provide the first evidence that NHE1 function plays an important role in glioma-microglia interactions, enhancing glioma proliferation and invasion by stimulating microglial release of soluble factors. NHE1 upregulation is a novel marker of the glioma-associated microglial activation phenotype. Inhibition of NHE1 represents a novel glioma therapeutic strategy by targeting tumor-induced microglial activation.
小胶质细胞在胶质瘤的细胞外基质重塑、肿瘤侵袭、血管生成及适应性免疫抑制中发挥重要作用。钠氢交换体1型(NHE1)调节小胶质细胞的激活和迁移。然而,关于NHE1在肿瘤内小胶质细胞激活及小胶质细胞与胶质瘤相互作用中的作用知之甚少。我们的研究显示,在胶质瘤异种移植瘤和多形性胶质母细胞瘤微阵列中,胶质瘤细胞和肿瘤相关的Iba1(+)小胶质细胞中NHE1蛋白表达均上调。此外,我们观察到小胶质细胞/巨噬细胞中NHE1表达与Iba1强度呈正相关。胶质瘤细胞通过条件培养基或非接触式胶质瘤-小胶质细胞共培养,同时上调小胶质细胞NHE1蛋白表达及其他小胶质细胞激活标志物(诱导型一氧化氮合酶、精氨酸酶-1、转化生长因子-β、白细胞介素-6、白细胞介素-10以及基质金属蛋白酶MT1-MMP和MMP9)的表达。有趣的是,胶质瘤刺激的小胶质细胞反过来增强了胶质瘤的增殖和迁移。最重要的是,通过小干扰RNA(siRNA)敲低或强效NHE1特异性抑制剂HOE642抑制小胶质细胞NHE1活性,可显著减弱小胶质细胞激活,并消除小胶质细胞刺激的胶质瘤迁移和增殖。综上所述,我们的研究结果首次证明,NHE1功能在胶质瘤-小胶质细胞相互作用中起重要作用,通过刺激小胶质细胞释放可溶性因子增强胶质瘤的增殖和侵袭。NHE1上调是胶质瘤相关小胶质细胞激活表型的一个新标志物。抑制NHE1代表了一种通过靶向肿瘤诱导的小胶质细胞激活的新型胶质瘤治疗策略。